MedPath

University of North Carolina

🇺🇸United States
Ownership
-
Established
1789-01-01
Employees
-
Market Cap
-
Website
https://northcarolina.edu

Clinical Trials

17

Active:0
Completed:17

Trial Phases

4 Phases

Phase 1:3
Phase 2:1
Phase 4:2
+1 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (16 trials with phase data)• Click on a phase to view related trials

Not Applicable
10 (62.5%)
Phase 1
3 (18.8%)
Phase 4
2 (12.5%)
Phase 2
1 (6.3%)

Shared Decision Making for Prostate Cancer Screening: a Practice-Based Randomized Controlled Trial

Not Applicable
Completed
Conditions
Prostatic Neoplasms
First Posted Date
2008-03-06
Last Posted Date
2008-03-06
Lead Sponsor
University of North Carolina
Target Recruit Count
128
Registration Number
NCT00630188
Locations
🇺🇸

Chapel Hill North General Internal Medicine Practice, Chapel Hill, North Carolina, United States

🇺🇸

University of North Carolina at Chapel Hill General Medicine Clinic, Chapel Hill, North Carolina, United States

🇺🇸

Moses Cone Internal Medicine Practice, Greensboro, North Carolina, United States

and more 1 locations

Efficacy of Yogurt Containing BB12 in Subjects With GI Symptoms

Not Applicable
Completed
Conditions
Pain
First Posted Date
2008-02-20
Last Posted Date
2008-02-20
Lead Sponsor
University of North Carolina
Target Recruit Count
63
Registration Number
NCT00618488
Locations
🇺🇸

University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States

Phase I Clinical Study of Soy Isoflavones in Healthy, Post-Menopausal Women

Phase 1
Completed
Conditions
Drug Toxicity
First Posted Date
2007-06-26
Last Posted Date
2007-06-26
Lead Sponsor
University of North Carolina
Target Recruit Count
36
Registration Number
NCT00491595

Development and Evaluation of A Mailed Arthritis Self-Management Program

Not Applicable
Completed
Conditions
Osteoarthritis
Rheumatoid Arthritis
First Posted Date
2007-03-16
Last Posted Date
2007-03-16
Lead Sponsor
University of North Carolina
Target Recruit Count
900
Registration Number
NCT00448474
Locations
🇺🇸

University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States

Improving Medication Use in Patients With Hypertension

Not Applicable
Completed
Conditions
Hypertension
First Posted Date
2006-10-17
Last Posted Date
2006-10-17
Lead Sponsor
University of North Carolina
Target Recruit Count
492
Registration Number
NCT00388817
Locations
🇺🇸

School of Pharmacy, UNC-Chapel Hill, CB 7360, Chapel Hill, North Carolina, United States

  • Prev
  • 1
  • 2
  • 3
  • 4
  • Next

News

Digital Inhaler Technology Shows Promise for Early COPD Exacerbation Detection

Digital inhalers can detect significant physiologic changes up to two weeks before COPD exacerbations occur, potentially enabling earlier clinical intervention.

Study Identifies Why Venetoclax-Based AML Treatment Fails in Certain Patients

Researchers analyzed 678 AML patients and found that both gene mutations and leukemia cell maturity affect response to venetoclax plus hypomethylating agents treatment.

First Patient Dosed in Phase 2 OASIS Trial of TNX-102 SL for Acute Stress Reaction Following Trauma

Tonix Pharmaceuticals has initiated dosing in the Phase 2 OASIS trial evaluating TNX-102 SL for reducing acute stress reaction severity and acute stress disorder frequency following traumatic events.

Patient-Reported Physical Function Predicts Daratumumab Efficacy in Multiple Myeloma Patients

New research reveals patient-reported physical function serves as a superior prognostic indicator for multiple myeloma treatment outcomes compared to traditional physician assessments.

BioXcel Therapeutics Advances Phase 3 Trials for BXCL501 in Agitation Treatment

BioXcel Therapeutics has initiated the SERENITY At-Home Phase 3 trial evaluating BXCL501 for acute agitation in patients with bipolar disorders or schizophrenia, addressing an estimated 23 million annual episodes.

UNC Researchers Lead Groundbreaking HIV Clinical Trials in Vietnam

UNC researchers Vivian Go and Dr. Bill Miller are conducting multiple clinical trials in Vietnam, focusing on HIV care retention and prevention strategies for high-risk populations.

Maui Derm NP+PA Fall 2024 Conference to Spotlight Latest Advances in Dermatology Treatment

The four-day Maui Derm NP+PA Fall 2024 conference, scheduled for September 15-18 at Gaylord Opryland, will provide comprehensive updates on dermatological advances for nurse practitioners and physician assistants.

Dostarlimab Achieves 100% Complete Response Rate in Rectal Cancer Trial with Mismatch Repair Deficiency

A phase 2 clinical trial at Memorial Sloan Kettering Cancer Center found that dostarlimab achieved complete cancer remission in all 14 patients with locally advanced rectal cancer harboring mismatch repair deficiency mutations.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.